title: The authors reply.
authors.affiliation: Division of Infectious Disease, University of California San Francisco, San Francisco, CA Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, and Department of Medicine, Brigham and Women's Hospital, Boston, MA.
authors.forename: Sarah C
authors.initials: SC
authors.lastname: Lewis
authors.forename: Michael V
authors.initials: MV
authors.lastname: Murphy
authors.forename: Michael
authors.initials: M
authors.lastname: Klompas
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D053717:Pneumonia, Ventilator-Associated / Q000188:drug therapy* / Q000209:etiology*; D012121:Respiration, Artificial / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents